DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations. (October 2022)

• Record Type: Journal Article
• Authors: Ngoi, N.; Pilie, P.G.; Piha-Paul, S.A.; Dumbrava, E.E.; Fu, S.; Hong, D.S.; Karp, D.D.; Naing, A.; Pant, S.; Rodon Ahnert, J.; Subbiah, V.; Tsimberidou, A.M.; Salguero, C.; Brown, C.V.; Hoadley, W.E.; Johnson, A.; Yuan, Y.; Westin, S.N.; Meric-Bernstam, F.; Yap, T.A.
• Is Part Of: European journal of cancer. Volume 174(2022)Supplement 1
• Page Start: S10
• Publication Date: 2022-10
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(22)00828-0
• Languages: English
• ISSNs: 0959-8049